Electrical Therapeutic Systems Patents (Class 607/2)
  • Patent number: 10722282
    Abstract: A method for reshaping a nasal airway in a patient involves advancing an inflatable balloon of a reshaping device in an uninflated configuration into a nostril of the patient and between a nasal septum and a lateral wall of the nasal airway. The method then involves inflating the inflatable balloon to an inflated configuration to cause the inflatable balloon to contact nasal mucosa covering the nasal septum and the lateral wall, delivering energy from an energy delivery member attached to or inside of the inflatable balloon, and removing the reshaping device from the nasal airway.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: July 28, 2020
    Assignee: AERIN MEDICAL, INC.
    Inventors: Scott J. Wolf, Andrew Frazier
  • Patent number: 10709888
    Abstract: An electrical stimulation lead includes a lead body; a terminal disposed along the proximal end portion of the lead body; a single electrode disposed at the distal end of the lead body; a conductor extending along the lead body and electrically coupling the terminal to the single electrode; and an adjustable sheath disposed over a portion of the lead body to cover a selected portion of the single electrode by displacing the sheath forwards or backwards relative to the single electrode to control a size of a portion of the electrode exposed for stimulation of tissue. Another electrical stimulation lead has a low-profile distal portion that has a smaller lateral width in at least one direction than a remainder of the lead body. Yet another arrangement includes a guidewire with a mapping electrode to map a region around a peripheral nerve prior to implantation of an electrical stimulation lead.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: July 14, 2020
    Inventor: Anne Margaret Pianca
  • Patent number: 10695569
    Abstract: Methods and apparatuses for stimulation of the vagus nerve to treat inflammation including adjusting the stimulation based on one or more metric sensitive to patient response. The one or more metrics may include heart rate variability, level of T regulatory cells, particularly memory T regulatory cells, temperature, etc. Stimulation may be provided through an implantable microstimulator.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: June 30, 2020
    Assignee: SetPoint Medical Corporation
    Inventors: Jacob A. Levine, Michael A. Faltys, Jesse M. Simon
  • Patent number: 10675460
    Abstract: An insulated electrode system for delivering a plurality of tumor treating electromagnetic fields including an array of electrode elements for proximate location on a body of a patient. Each electrode element of the array having an insulation layer. Each electrode element being independently electrically accessible and configured to be assigned to emanate an electromagnetic field relative to at least one other of the electrode elements.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: June 9, 2020
    Assignee: Loyalty Based Innovations, LLC
    Inventors: Peter F. Travers, Ken Watkins, Timothy VanderMey
  • Patent number: 10661083
    Abstract: A CFS system includes self-adhesive, disposable pads. Each pad is combined with a sealed, cleanable battery/controller pod and then placed on the body where needed. The battery/controller pod preferably has wireless capability, such as Bluetooth® capability. The patient can download an application to a smartphone or similar mobile device to control the pods.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: May 26, 2020
    Assignee: Meagan Medical, Inc.
    Inventors: William J. Carroll, Mark E. Schoening, Patrick A. Scranton, William R. Huseby
  • Patent number: 10653883
    Abstract: Disclosed herein are methods, systems, and apparatus for treating a medical condition in a patient using an implantable medical device (IMD). The IMD is capable of generating a first electrical signal for treating a medical condition, for example epilepsy. The first electrical signal relates to a long term therapy during a first time period in which there is no indication that the patient's brain is in an stable state, the first electrical signal being a microburst stimulation signal. The implantable device is also capable of generating a second electrical signal for treating the medical condition. The second electrical signal relates to a short term therapy during a second time period, in response to an indication that the patient's brain is in an unstable state. The second electrical signal in one example, may be a conventional stimulation signal.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: May 19, 2020
    Assignee: LivaNova USA, Inc.
    Inventor: Timothy L. Scott
  • Patent number: 10632309
    Abstract: The present invention reduces pain and improves function long-term in persons with back pain using electrical stimulation in the back. This approach involves an electrical stimulation device including at least one electrode adapted for insertion within an animal body with back pain and at least one pulse generator operatively coupled with the at least one electrode, wherein the pulse generator delivers electrical stimulation activating at least a nerve innervating at least a paraspinal muscle in a back of the animal body for pain relief.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: April 28, 2020
    Inventors: Meredith McGee, Joseph W. Boggs, II, John Chae, Amorn Wongsarnpigoon, Maria E. Bennett
  • Patent number: 10632294
    Abstract: Devices and methods are provided for transmucosal drug delivery. The transmucosal drug delivery device may include a housing configured for intralumenal deployment, such as intravaginally, into a human or animal subject; a drug-dispensing portion which contains at least one drug, the drug-dispensing portion being configured to dispense the drug from the housing by positive displacement; and a permeability enhancer-dispensing portion configured to release or generate a permeability enhancing substance to disrupt at least one region of a mucosal barrier adjacent to the housing at a selected time while intralumenally deployed in the human or animal subject. The device may be operable to dispense the drug from the housing to a region of the mucosal barrier disrupted by the permeability enhancing substance.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: April 28, 2020
    Assignee: Palo Alto Research Center Incorporated
    Inventors: Scott Uhland, Eric Peeters, Hussain Fatakdawala
  • Patent number: 10625091
    Abstract: A transcranial magnetic stimulation coil which is location-specific for medial brain regions or lateral brain regions is designed with multiple spaced apart stimulating elements having current flow in a first direction, and multiple return elements having current flow in a second direction which is opposite the first direction. The multiple stimulating elements are distributed around a central axis of the coil.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: April 21, 2020
    Assignee: BRAINSWAY, LTD.
    Inventors: Abraham Zangen, Yiftach Roth
  • Patent number: 10617877
    Abstract: An electromedical implant, having a housing with three housing segments A, B and C. Segment A is joined to segment B, and segment B is joined to segment C, so that segment B is disposed between segments A and C. Segment A and segment C are at least partially made of electrically conducting material. Furthermore, an electronics module is disposed within housing segment A and has an electric circuit arrangement for picking up and further processing electrical signals, and at least one first and one second electrical conductor for measuring electrical potentials and/or for delivering electric pulses. Each conductor has a conductor start and a conductor end, and each conductor start is connected to the electric circuit arrangement. An electrical feedthrough is at least partially made of electrically insulating material, and segment B is formed by portions of the feedthrough.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: April 14, 2020
    Assignee: BIOTRONIK SE & Co. KG
    Inventors: Marcel Starke, Jan Romberg
  • Patent number: 10610683
    Abstract: A patch for a therapeutic electrical stimulation device includes a shoe connected to the first side of the patch, the shoe including a body extending in a longitudinal direction from a first end to a second end, and having first and second surfaces, the first end of the shoe defining at least two ports, and the first surface of the shoe defining a connection member. The patch also includes at least one conductor positioned in the ports of the first end of the shoe. The shoe is configured for sliding insertion into a receptacle defined by a controller so that the conductor is connected to the controller to deliver electrical current from the controller, through the conductor, and to the electrodes, and the connection member is at least partially captured by a detent defined by the controller in the receptacle to retain the shoe within the receptacle.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: April 7, 2020
    Assignee: DJO, LLC
    Inventors: Thomas Jerome Bachinski, Richard Paul Shindley, Dennis Lutz
  • Patent number: 10602950
    Abstract: The present approach relates to the fabrication and use of a probe array having multiple individual probes. In one embodiment, the probes of the probe array may be functionalized such that certain of the probes are suitable for electrical sensing (e.g., recording) or stimulation, non-electrical sensing or stimulation (e.g., chemical sensing and/or release of biomolecules when activated), or a combination of electrical and non-electrical sensing or stimulation.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: March 31, 2020
    Inventors: Jeffrey M. Ashe, Kaustubh Ravindra Nagarkar, Christopher Michael Puleo, Christopher Fred Keimel, Craig Patrick Galligan, Yizhen Lin, Nancy Cecelia Stoffel, Richard Vanfleet, Robert Davis, Guohai Chen
  • Patent number: 10603502
    Abstract: In one aspect, implantable wireless microstimulators are described herein. In some embodiments, a microstimulator described herein includes an energy harvesting circuit configured to receive an input signal and generate an electrical signal based on the received input signal. The microstimulator further comprises a diode rectifier in series with the energy harvesting circuit. The diode rectifier is configured to rectify the electrical signal. The energy harvesting circuit and the diode rectifier can be encapsulated within a biocompatible electrically insulating material. Additionally, in some cases, an electrical interface is exposed through the biocompatible electrically insulating material. A microstimulator described herein can also include a nerve cuff. The nerve cuff can be configured to receive a monophasic neural stimulation pulse through the electrical interface of the micro stimulator.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: March 31, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Stuart Cogan, Daniel Kenneth Freeman, Jonathan Michael O'Brien, Mario Romero-Ortega
  • Patent number: 10603484
    Abstract: The disclosure describes devices and systems that include a grounding electrode. In one example, a system may include a first module including a pulse generator within a first housing, a second module comprising a switch matrix within a second housing distinct from the first housing, a connecting cable that connects the first module to the second module, a grounding electrode disposed distal of the first module and proximal of the second module, and a plurality of electrodes disposed distal of the second module, wherein each electrode of the plurality of electrodes are selectively coupled to the pulse generator via the switch matrix. These devices or system can be used to provide neurostimulation and/or neurorecording.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: March 31, 2020
    Assignee: Medtronic Bakken Research Center B.V.
    Inventors: Egbertus Johannes Maria Bakker, Matthew Finlay, Sébastien Jody Ouchouche, Jeroen Jacob Arnold Tol
  • Patent number: 10596373
    Abstract: A method for providing electrical stimulation to a user as a user performs a set of tasks during a time window, the method comprising: providing an electrical stimulation treatment, characterized by a stimulation parameter and a set of portions, to a brain region of the user in association with the time window; for each task of the set of tasks: receiving a signal stream characterizing a neurological state of the user; from the signal stream, identifying a neurological signature characterizing the neurological state associated with the task; and modulating the electrical stimulation treatment provided to the brain region of the user based upon the neurological signature, wherein modulating comprises delivering a portion of the set of portions of the electrical stimulation treatment to the brain region of the user, while maintaining an aggregate amount of the stimulation parameter of the treatment provided during the time window below a maximum limit.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: March 24, 2020
    Assignee: Halo Neuro, Inc.
    Inventors: Brett Wingeier, Daniel S. Chao, Lee von Kraus, Amol Sarva, Sophia Sanchez
  • Patent number: 10589096
    Abstract: This invention relates generally to systems and methods for multifocal direct brain stimulation to enhance cognitive processing, such as but not limited to stimulation-induced modulation of memory.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: March 17, 2020
    Inventor: Nitin Tandon
  • Patent number: 10588999
    Abstract: Techniques for creating a mesoporous surface for enhanced bone integration are provided. An example of a method for generating a mesoporous surface on a substrate includes depositing a layer of titanium on an area of the substrate to generate a nano-textured surface, and anodizing the layer of titanium on the area of the substrate to generate the mesoporous surface. The method may also include incorporating pharmaceutical, biological, or molecular additives into the mesoporous surface intended to further enhance performance of the substrate via enhanced osseoconduction, osseoinduction, or antimicrobial/anti-infective properties.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: March 17, 2020
    Assignee: N2 BIOMEDICAL LLC
    Inventors: Nader Montazemezam Kalkhoran, Eric Tobin, Jason Burns
  • Patent number: 10583224
    Abstract: An implant comprising at least three components, namely, a solid hydrogel, a porous hydrogel adjacent to or surrounding the solid hydrogel (together considered “the hydrogel”), and a porous rigid base. The solid hydrogel and porous rigid base carry joint load, and the porous hydrogel layer and the porous rigid base allow for cellular migration into and around the implant. The invention is also a novel method of manufacturing the implant, a novel method of implanting the implant, and a method of treating, repairing or replacing biological tissue, more preferably musculoskeletal tissue, with the implant.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: March 10, 2020
    Inventors: Suzanne A. Maher, Tony Chen, Joseph D. Lipman, Peter Torzilli, Russell Warren
  • Patent number: 10576272
    Abstract: This invention provides a device for implantation directly into the spinal cord for the purpose of treating back pain. Electrodes on a backing that conforms directly to the spinal cord are installed as a source of electrical stimulation and pain relief. The floating electrodes can be flexibly mounted to the substrate such that when the electrode array is implanted into the subject, individual electrodes float or move resiliently relative to the substrate to an extent sufficient to accommodate pulsations of the surface of the spinal cord within the dura.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: March 3, 2020
    Assignee: University of Iowa Research Foundation
    Inventor: Matthew A. Howard
  • Patent number: 10576287
    Abstract: A system for delivering an electrical stimulation pulse to tissue comprises a controller-transmitter and a receiver-stimulator. The controller-transmitter includes circuitry having an energy storage capacitor. The capacitance of the energy storage capacitor is adjusted to improve the efficiency of energy delivered from the receiver-stimulator to tissue by modifying the geometry of an acoustic drive burst from the controller-transmitter.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: March 3, 2020
    Assignee: EBR Systems, Inc.
    Inventor: Mark W. Cowan
  • Patent number: 10576266
    Abstract: A method of forming a medical device contact element includes annealing an elongated rod of Ti-15Mo alloy material to form an annealed rod having a Young's Modulus of less than 13.5 Mpsi and an elastic range or strain of at least 0.7%. Then forming a contact ring element from the annealed rod and assembling the contact ring element into a medical device. Contact rings and lead receptacles including the same are also described.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: March 3, 2020
    Assignee: Medtronic, Inc.
    Inventors: Bernard Q. Li, Alan Shi, Daniel D. Sorensen, Darren A. Janzig, Margaret Bush
  • Patent number: 10569084
    Abstract: A device and method are provided for altering body mass composition in a human subject by applying galvanic vestibular stimulation (GVS) using electrodes placed in electrical contact with the subject's scalp at a location corresponding to each of the subject's left and right vestibular systems. The current source includes a feedback loop for measuring a resistance across the subject's scalp and adjusting a voltage output to maintain a constant current across the subject's scalp. GVS may be applied for a predetermined period of time at regular intervals.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: February 25, 2020
    Inventors: Paul Duncan McGeoch, Vilayanur S. Ramachandran
  • Patent number: 10561330
    Abstract: An implantable medical device (IMD) may include a sensor for providing a sensor output signal and a sense channel configured to receive the sensor output signal from the sensor. The sense channel may be configured to process the sensor output signal and output a sense channel output signal. The sense channel may have an adjustable performance level, wherein for a higher performance level the sense channel consumes more power than for a lower performance level. A controller may be configured to adjust the performance level of the sense channel to achieve more performance and more power consumption when a higher degree of sense channel performance is desired and to achieve less performance and less power consumption when a higher degree of performance is not desired.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: February 18, 2020
    Inventors: Aleksandra Kharam, Ron A. Balczewski, Paul Huelskamp, Lance Eric Juffer, Keith R. Maile
  • Patent number: 10565456
    Abstract: A system for monitoring a patient in a patient area having one or more detection zones, the system comprising one or more cameras, a user interface, and a computing system configured to receive a chronological series of frames from the one or more cameras, identify liquid candidates by comparing a current frame with a plurality of previous frames of the chronological series, determine locations of the liquid candidates, identify thermal signatures of the liquid candidates, determine types of liquids of the liquid candidates based on the locations and thermal signatures of the liquid candidates, and generate an alert with the user interface corresponding to the determined types of liquids.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: February 18, 2020
    Assignee: CareView Communications, Inc.
    Inventors: Steven Gail Johnson, Derek del Carpio, Kenneth W. Chapman
  • Patent number: 10548504
    Abstract: A tissue compression sensor system is disclosed. The tissue compression system includes an RF electrode positioned on an end-effector; a first electrical contact positioned on one of an anvil or a channel frame of the end-effector; and a first filter communicatively coupled to the first electrical contact.
    Type: Grant
    Filed: March 6, 2015
    Date of Patent: February 4, 2020
    Assignee: Ethicon LLC
    Inventors: Frederick E. Shelton, IV, David C. Yates, Jason L. Harris
  • Patent number: 10537385
    Abstract: Apparatus, systems, and methods for achieving thermally-induced renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a thermal element to a renal artery via an intravascular path. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers.
    Type: Grant
    Filed: July 19, 2017
    Date of Patent: January 21, 2020
    Assignee: Medtronic Ardian Luxembourg S.a.r.l.
    Inventors: Andrew Wu, Benjamin J. Clark, Denise Zarins, Erik Thai
  • Patent number: 10536177
    Abstract: A radio communication receiver and a method performed by the radio communication receiver for configuring a Notch filter of the radio communication receiver. The method comprises retrieving stored and previously determined filter coefficients from a set of filter coefficients, where the retrieved filter coefficients constitute a fraction of the total number of filter coefficients; and setting the rest of the filter coefficients to one. The method further comprises normalising the retrieved filter coefficients; and transforming the filter coefficients such that the Notch position ends up at the one or more frequencies to be filtered out.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: January 14, 2020
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Kazimierz Koziarz, Erik Larsson, Henrik Egnell
  • Patent number: 10517498
    Abstract: A cardiac rhythm management system includes a first implantable device such as a defibrillator and a second implantable device such as a leadless cardiac pacemaker. A programmer is configured to receive and display heart data emanating from the implantable defibrillator and from the leadless cardiac pacemaker. The heart data emanating from the leadless cardiac pacemaker is displayed in temporal alignment with the heart data emanating from the implantable defibrillator.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: December 31, 2019
    Inventors: Jeffrey E. Stahmann, Michael J. Kane, Paul Huelskamp, Keith R. Maile
  • Patent number: 10507311
    Abstract: A system for treatment of a wound area of a patient including a first treatment pad comprising a plurality of Light Emitting Diodes (LEDs) for cleaning and exposing a wound area to ultraviolet light, a second treatment pad comprising removal ports for exposing the wound area to a negative pressure, and a control unit interoperably connected to the first and second treatment pads for providing a negative pressure and the ultraviolet light to the wound area.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: December 17, 2019
    Assignee: ThermoTek, Inc.
    Inventor: Tony Quisenberry
  • Patent number: 10500394
    Abstract: A pacemaker system is configured to sense electrical and mechanical activity of the heart tissue within a mammalian body and to generate a corresponding signal responsive to the sensed cardiac activity. The system includes a flexible electrical generator that contains EKG (ECG) electrodes for measuring electrical activity and ECHO piezoelectric electrodes for measuring mechanical activity of the heart and Doppler blood flow. The generator is embedded in a flexible shield, and is contoured to conform to the anatomy of the intercostal space to be embedded between the ribs of a patient and in the position overlying the heart. The system provides for pacing as well as defibrillation, responsive to the readings of the heart activities. A microprocessor analyzes a cardiac situation, based on the sensor's readings, produces a diagnosis, and generates control signals, such as “pacing pulse” in a life-threatening situation, or “observe” in a non life-threatening situation.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: December 10, 2019
    Inventors: A-Hamid Hakki, A-Hadi Hakki
  • Patent number: 10493264
    Abstract: A TENS system is provided having an electrode element design accommodating improved motion mechanics and maneuverability while maintaining electrical contact. An electrode having a soft wing construction is provided such that a multi-planar flexibility is provided during operation. A range of motion hinge provides and positions at a central area of a winged configuration a housing such that both a rotational movement and an angular movement may occur while maintaining continuous, direct contact with the TENS electronics within the housing. A selected die-cut pattern of a number of designs may form a stepped-in wing configuration may further contribute to a lateral flexibility of the wings.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: December 3, 2019
    Inventor: Joshua A. Lefkovitz
  • Patent number: 10493294
    Abstract: A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity. Optionally, at least some tissue which is viable but lacks nervous control is ablated, for example, to reduce or avoid arrhythmia.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: December 3, 2019
    Assignee: Tylerton International Inc.
    Inventor: Shlomo Ben-Haim
  • Patent number: 10485970
    Abstract: Prophylactic stimulation and abortive electrical stimulation are delivered to a cranial nerve, including, e.g. an occipital or trigeminal nerve to treat symptoms of various conditions, including, e.g. occipital neuralgia or migraines.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: November 26, 2019
    Assignee: Medtronic, Inc.
    Inventors: Martin T. Gerber, Steven M. Goetz, Christopher Poletto
  • Patent number: 10482198
    Abstract: Cardiac catheterization is carried out by constructing a left atrial model of a heart of a living subject, selecting a global catheter that is dimensioned to conform to the left atrial model, representing the catheter in the left atrial model; extending the length axis of the catheter in the left atrial model to form an intersection with the foramen ovale, and reporting the intersection as a recommended site of transseptal puncture for insertion of the catheter therethrough.
    Type: Grant
    Filed: August 13, 2018
    Date of Patent: November 19, 2019
    Assignee: Biosense Webster (Israel) Ltd.
    Inventors: Shmuel Auerbach, Aharon Turgeman
  • Patent number: 10471268
    Abstract: System and method for rehabilitating a muscle and monitoring such rehabilitation are provided, the system including a user input receiver for receiving stimulation parameter inputs from a user, a stimulator for generating stimulations to be applied to a patient's body based on the stimulation parameter inputs, a signal receiver to receive, detect, and record a signal containing an evoked potential generated by the body in response to the stimulations, a signal processor for processing the recorded signal, for example, by amplifying, filtering, digitizing and temporal averaging the recorded signal, a trigger detector to alert the signal processor module when stimulations are generated to enable synchronization of the response signal with the stimulus for accurate temporal averaging, and an output display for providing data representative of the evoked potential to the user.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: November 12, 2019
    Assignee: Mainstay Medical Limited
    Inventors: Peter A. Crosby, Kristen N. Jaax, Prashant B. Rawat
  • Patent number: 10463854
    Abstract: A wearable device for treating dysmenorrhea in a patient includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation from the external surface of the patient's epidermal layer through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis by applying electrical stimulation to the epidermis of a T9 to T12, L1, L2, L5 and/or S1 to S4 dermatomes of the patient. The device includes a pad, in which the electrode is disposed, for secure placement of the device on a skin surface of the patient. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record menstruation-related patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: November 5, 2019
    Assignee: Elira, Inc.
    Inventor: Raul E. Perez
  • Patent number: 10456186
    Abstract: Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: October 29, 2019
    Assignee: AERIN MEDICAL, INC.
    Inventors: Scott J. Wolf, Andrew Frazier
  • Patent number: 10456117
    Abstract: Embodiments of the present disclosure disclose a method and a device for adjusting ultrasonic cavitation intensity. The adjusting method includes: controlling to adjust a jth cavitation coefficient according to an ith cavitation intensity value and a target cavitation intensity value, so as to calculate to obtain an (i+1)th cavitation intensity value; and continuing to control to adjust a (j+1)th cavitation coefficient according to the (i+1)th cavitation intensity value and the target cavitation intensity value, so as to calculate to obtain an (i+2)th cavitation intensity value if the absolute value of a difference between the (i+1)th cavitation intensity value and the target cavitation intensity value is greater than a set threshold value, and ending the method when it is determined that the absolute value of the difference between the (i+1)th cavitation intensity value and the target cavitation intensity value is less than or equal to the set threshold value.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: October 29, 2019
    Inventor: Huiren Chen
  • Patent number: 10448884
    Abstract: A device includes a handle, an expandable structure including a plurality of splines extending from a proximal hub to a distal hub, a first electrode on a first spline of the plurality of splines, an outer tube extending from the handle to the proximal hub, and a shaft extending through the outer tube from the handle to the distal hub. The expandable structure has a collapsed state and a self-expanded state. The handle is configured to retract the shaft. Retracting the shaft may expand the expandable structure outward of the self-expanded state.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: October 22, 2019
    Assignee: Cardionomic, Inc.
    Inventors: Steven D. Goedeke, Mark A. Christopherson, David J. Serdar, Steven C. Christian
  • Patent number: 10441807
    Abstract: The present disclosure relates to methods for treating diseases or conditions with pulsed electromagnetic field therapy, where the disease or condition treated is one susceptible to modulation of gene expression by pulsed electromagnetic field therapy. The present disclosure generally relates to methods of modulating gene expression and biological regulatory pathways with pulsed electromagnetic field therapy for treating diseases or conditions associated with such gene expression or regulatory pathways that are susceptible to modulation by pulsed electromagnetic therapy, including diseases or conditions associated with inflammation, nerve pain and wound repair.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: October 15, 2019
    Assignee: Regenesis Biomedical, Inc.
    Inventor: John Moffett
  • Patent number: 10426951
    Abstract: A medical tool includes a rotation mechanism that further includes a warning feature. The warning feature provides an indication when the rotation mechanism has achieved a number of rotations.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: October 1, 2019
    Assignee: PACESETTER, INC.
    Inventors: Thomas B. Eby, Bradley Knippel, Daniel Coyle, Jennifer Heisel, Bernhard Arnar, Brett Hillukka, Tracee Eidenschink, Paul Paspa, Joseph Ramon Callol
  • Patent number: 10420950
    Abstract: An implantable pulse generator (IPG) allowing for trial stimulation in a fully implanted solution is disclosed. At the time the leads are implanted, a micro IPG having lead connection block(s) is also implanted and connected to the leads. To keep the micro IPG suitably small, it preferably does not include a battery, and is instead powered continuously via magnetic induction using a magnetic field produced by an external charger, such as a charging patch. A coil in the micro IPG picks up and rectifies this magnetic field to provide power to stimulating electronics in the IPG. Because of its small size (e.g., ?10 cm3), implantation of the micro IPG can occur at the same time the leads are implanted in the patient without inconvenience. Should stimulation therapy with the micro IPG prove effective, a larger, permanent IPG can later be implanted and connected to the implanted leads.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: September 24, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jordi Parramon, Anne Pianca, Bernard Malinowski, William G. Orinski
  • Patent number: 10421955
    Abstract: A method of culturing cells or tissue comprises: (a) disposing cells or tissue in the cavity of a deformable cell culture container; and (b) applying synchronized chronic electrical stimulation and stretch to the cells or tissue in the deformable culture cell container, wherein the synchronized chronic electrical stimulation is applied in the form of pulses at a frequency of from 0.010-99 Hz and a duration of from 0.4 to 24 ms; and wherein stretch cycles are applied to the cells or tissue at a frequency of from 0.010 to 15 Hz.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: September 24, 2019
    Assignee: IONOPTIX LLC
    Inventors: Peter G. W. Lee, Douglas L. Tillotson, Richard T. Udale, Katherine L. Barber
  • Patent number: 10413739
    Abstract: An implantable control module for an electrical stimulation system includes a connector housing including a connector having one or more ports and connector contacts disposed within the connector; a metal electronics housing coupled to the connector housing; an electronic subassembly disposed within the metal electronics housing; and a feedthrough assembly disposed between the connector housing and the metal electronics housing and including at least one non-conductive block and conductive feedthroughs extending through the at least one non-conductive block and electrically coupling the electronic subassembly to the connector contacts. The metal electronics housing includes a metal sheet bent to form at least a portion of the first major surface and at least a portion of the second major surface. The first major surface has a length and includes a first sealed seam extending along an entirety of the length of the first major surface.
    Type: Grant
    Filed: January 26, 2016
    Date of Patent: September 17, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Jeffery Van Funderburk
  • Patent number: 10413742
    Abstract: A patient parameter monitoring pod in embodiments of the teachings may include one or more of the following features: (a) portable housing containing a power supply, (b) a patient parameter module connectable to a patient via lead cables to collect patient data, the patient data including at least one vital sign, (c) a transceiver adapted to wirelessly transmit the patient data to a defibrillator, (d) a data port adapted to supply the patient data via a direct electrical connection to the defibrillator, and (e) a carrying handle extending from the housing proximate a patient lead cable port that permits connection of the lead cables to the pod, the carrying handle positioned to protect the patient lead cable port and the patient lead cables attached to the port from direct impact.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: September 17, 2019
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Michael D. McMahon, Christopher Pearce, Peter Wung, John C. Daynes, Kenneth J. Peterson, Maren L. Nelson, James S. Neumiller
  • Patent number: 10405767
    Abstract: A portable medical device having an intravenous line flow sensor integrated into a cable. The portable medical device may be a defibrillator having an ECG or electrode cable couple to ECG or electrode leads. The flow sensor may be integrated into the ECG or electrode cable. The portable medical device uses the flow sensor to capture and store information about fluids delivered to a patient being treated with the portable medical device. The information may include total volume provided, flow rate, and the like. The information may then be used to evaluate the treatment provided to the patient.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: September 10, 2019
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Robert G. Walker, Barry D. Curtin
  • Patent number: 10391329
    Abstract: Described are methods for the improvement of neural communication between implanted and existing tissue. Methods herein use synchronous low frequency magnetic or electric stimulation of both regions to enhance communication and facilitate regeneration of nerve fibers across the tissue interface.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: August 27, 2019
    Inventor: Yi Jin
  • Patent number: 10391322
    Abstract: Timing channel circuitry for controlling stimulation circuitry in an implantable stimulator is disclosed. The timing channel circuitry comprises a addressable memory. Data for the various phases of a desired pulse are stored in the memory using different numbers of words, including a command indicative of the number of words in the phase, a next address for the next phase stored in the memory, and a pulse width or duration of the current phase, control data for the stimulation circuitry, pulse amplitude, and electrode data. The command data is used to address through the words in the current phase via the address bus, which words are sent to a control register for the stimulation circuitry. After the duration of the pulse width for the current phase has passed, the stored next address is used to access the data for the next phase stored in the memory.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: August 27, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Paul J. Griffith, Goran N. Marnfeldt, Jordi Parramon
  • Patent number: 10391298
    Abstract: Methods and devices are provided for activating brown adipose tissue (BAT) using electrical energy. In general, the methods and devices can facilitate activation of BAT to increase thermogenesis. The BAT can be activated by applying an electrical signal thereto that can be configured to target sympathetic nerves that can directly innervate the BAT. The electrical signal can be configured to target the sympathetic nerves using fiber diameter selectivity. In other words, the electrical signal can be configured to activate nerve fibers having a first diameter without activating nerve fibers having diameters different than the first diameter. Sympathetic nerves include postganglionic unmyelinated, small diameter fibers, while parasympathetic nerves that can directly innervate BAT include preganglionic myelinated, larger diameter fibers.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: August 27, 2019
    Assignee: Ethicon LLC
    Inventors: Jason L. Harris, Tamara C. Baynham
  • Patent number: RE48024
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: June 2, 2020
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Sidney F. Hauschild, Paula M. Kaplan, Brian D. Kuhnley, Keith E. Jasperson, Wondimeneh Tesfayesus, Christopher K. Thorp